Pang Hui-Lin, Zhu Guang-Hao, Zhou Qi-Hang, Ai Chun-Zhi, Zhu Ya-Di, Wang Ping, Dou Tong-Yi, Xia Yang-Liu, Ma Hong, Ge Guang-Bo
School of Life and Pharmaceutical Sciences, Dalian University of Technology, Panjin, China.
Shanghai Frontiers Science Center for Chinese Medicine Chemical Biology, Institute of Interdisciplinary Integrative Medicine Research, Shanghai University of Traditional Chinese Medicine, Shangha, China.
Front Pharmacol. 2022 Feb 21;13:815235. doi: 10.3389/fphar.2022.815235. eCollection 2022.
Human UDP-glucuronosyltransferase 1A1 (hUGT1A1) is one of the most essential phase II enzymes in humans. Dysfunction or strong inhibition of hUGT1A1 may result in hyperbilirubinaemia and clinically relevant drug/herb-drug interactions (DDIs/HDIs). Recently, a high-throughput fluorescence-based assay was constructed by us to find the compounds/herbal extracts with strong inhibition against intracellular hUGT1A1. Following screening of over one hundred of herbal products, the extract of leaves (GBL) displayed the most potent hUGT1A1 inhibition in HeLa-UGT1A1 cells (Hela cells overexpressed hUGT1A1). Further investigations demonstrated that four biflavones including bilobetin, isoginkgetin, sciadopitysin and ginkgetin, are key constituents responsible for hUGT1A1 inhibition in living cells. These biflavones potently inhibit hUGT1A1 in both human liver microsomes (HLM) and living cells, with the IC values ranging from 0.075 to 0.41 μM in living cells. Inhibition kinetic analyses and docking simulations suggested that four tested biflavones potently inhibit hUGT1A1-catalyzed NHPN--glucuronidation in HLM a mixed inhibition manner, showing the values ranging from 0.07 to 0.74 μM. Collectively, our findings uncover the key constituents in GBL responsible for hUGT1A1 inhibition and decipher their inhibitory mechanisms against hUGT1A1, which will be very helpful for guiding the rational use of GBL-related herbal products in clinical settings.
人尿苷二磷酸葡萄糖醛酸基转移酶1A1(hUGT1A1)是人体最重要的II相酶之一。hUGT1A1功能障碍或受到强烈抑制可能导致高胆红素血症以及具有临床意义的药物/草药-药物相互作用(DDIs/HDIs)。最近,我们构建了一种基于荧光的高通量检测方法,以寻找对细胞内hUGT1A1具有强烈抑制作用的化合物/草药提取物。在对一百多种草药产品进行筛选后,银杏叶提取物(GBL)在HeLa-UGT1A1细胞(过表达hUGT1A1的HeLa细胞)中表现出最强的hUGT1A1抑制作用。进一步研究表明,包括白果素、异银杏双黄酮、榧黄素和银杏双黄酮在内的四种双黄酮是活细胞中hUGT1A1抑制作用的关键成分。这些双黄酮在人肝微粒体(HLM)和活细胞中均能有效抑制hUGT1A1,在活细胞中的IC值范围为0.075至0.41μM。抑制动力学分析和对接模拟表明,四种测试双黄酮以混合抑制方式有效抑制HLM中hUGT1A1催化的NHPN-葡萄糖醛酸化反应,其Ki值范围为0.07至0.74μM。总的来说,我们的研究结果揭示了GBL中负责hUGT1A1抑制的关键成分,并阐明了它们对hUGT1A1的抑制机制,这将有助于指导GBL相关草药产品在临床环境中的合理使用。